Monosialoganglioside in Acute Ischemic Stroke: a Randomized, Blinded and Multicenter Confirmatory Study
Clinical trial NCT06742216 · COMPLETED
Trial details
- NCT number
- NCT06742216
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-03
- Primary completion
- 2023-08-30
- Enrollment
- 1232
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.